Written by The Animal Biotechnology Market is developing rapidly through advances in genetic engineering, reproductive biotechnology, molecular diagnostics, and animal healthcare. The market is forecast to grow from USD 21.41 billion in 2025 to USD 58.44 billion by 2035 at a CAGR of 10.56%. Growing demand for improved animal health and productivity is supporting this expansion.
Modern biotechnology is being applied across livestock production, veterinary diagnostics, pet care, reproductive technologies, and other areas. Gene editing and genomics can support the development of animals with selected traits, while biotechnology-based diagnostics and therapeutics can contribute to disease prevention and management. Research collaborations are also accelerating the development of new technologies.
The market includes applications such as Genetic Engineering, Molecular Diagnostics, Animal Health, Reproductive Biotechnology, and Transgenic Animals. Animal Health is currently the largest application segment, with a 2024 valuation of approximately USD 5.67 billion. Gene Editing is the dominant technology, while Stem Cell Technology is projected to grow from USD 5.57 billion in 2024 to USD 17.34 billion by 2035.
Asia-Pacific is becoming an important growth market as countries such as China and India expand livestock production and invest in agricultural biotechnology. North America continues to benefit from strong research capabilities and animal-health demand, while Europe is focusing on sustainable agricultural practices and animal welfare. These regional developments are expected to influence the market outlook through 2035.
4.
The Animal Biotechnology Market is gaining importance as biotechnology contributes to animal health, sustainable agriculture, and food production. Market Research Future projects the market to reach USD 58.44 billion by 2035 from USD 19.37 billion in 2024, reflecting a CAGR of 10.56% during 2025–2035.
Rising demand for meat, dairy, and other animal-derived products is encouraging producers to improve productivity and disease management. Advances in genetic engineering, CRISPR, and other biotechnology techniques are supporting research into improved animal traits. Regulatory developments and government funding for biotechnology research are also influencing market development.
Animal Health is the leading application segment, supported by demand for vaccines, diagnostics, and therapeutics. Genetic Engineering is another important application, while Gene Editing dominates the technology segment. Pharmaceuticals represent the largest end-use category, and Agriculture is identified as the fastest-growing end-use segment as biotechnology becomes more integrated into livestock production.
North America has a strong position in the market, with a 2024 regional value of approximately USD 9.5 billion. Europe was valued at around USD 5.0 billion, while Asia-Pacific reached approximately USD 3.5 billion. Expanding biotechnology capabilities, animal-health investments, and demand for sustainable food production are expected to support continued market growth.
Strengthen your strategy with data-backed research insights: